Cite
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
MLA
Biehl, Lena M., et al. “A Cohort Study on Breakthrough Invasive Fungal Infections in High-Risk Patients Receiving Antifungal Prophylaxis.” Journal of Antimicrobial Chemotherapy (JAC), vol. 71, no. 9, Sept. 2016, pp. 2634–41. EBSCOhost, https://doi.org/10.1093/jac/dkw199.
APA
Biehl, L. M., Vehreschild, J. J., Liss, B., Franke, B., Markiefka, B., Persigehl, T., Bücker, V., Wisplinghoff, H., Scheid, C., Cornely, O. A., & Vehreschild, M. J. G. T. (2016). A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis. Journal of Antimicrobial Chemotherapy (JAC), 71(9), 2634–2641. https://doi.org/10.1093/jac/dkw199
Chicago
Biehl, Lena M., J. Janne Vehreschild, Blasius Liss, Bernd Franke, Birgid Markiefka, Thorsten Persigehl, Vanessa Bücker, et al. 2016. “A Cohort Study on Breakthrough Invasive Fungal Infections in High-Risk Patients Receiving Antifungal Prophylaxis.” Journal of Antimicrobial Chemotherapy (JAC) 71 (9): 2634–41. doi:10.1093/jac/dkw199.